Entrada Therapeutics Inc
NASDAQ:TRDA

Watchlist Manager
Entrada Therapeutics Inc Logo
Entrada Therapeutics Inc
NASDAQ:TRDA
Watchlist
Price: 15.47 USD -1.02% Market Closed
Updated: Jun 2, 2024

Entrada Therapeutics Inc
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Entrada Therapeutics Inc
Common Shares Outstanding Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Entrada Therapeutics Inc
NASDAQ:TRDA
Common Shares Outstanding
$33.4m
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Common Shares Outstanding
$1.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Common Shares Outstanding
$1.2B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Common Shares Outstanding
$536.4m
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Common Shares Outstanding
$258.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Common Shares Outstanding
$110.2m
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
1%

See Also

What is Entrada Therapeutics Inc's Common Shares Outstanding?
Common Shares Outstanding
33.4m USD

Based on the financial report for Dec 31, 2023, Entrada Therapeutics Inc's Common Shares Outstanding amounts to 33.4m USD.

What is Entrada Therapeutics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 3Y
4%

Over the last year, the Common Shares Outstanding growth was 6%. The average annual Common Shares Outstanding growth rates for Entrada Therapeutics Inc have been 4% over the past three years .